Lorenzo has overall responsibilities for Hatch’s investing and operating activities. He is a scientist, investor and entrepreneur with 30 years of experience in the life sciences and is committed to translating scientific discoveries into products that make a difference in patients’ lives.

Lorenzo is the founder or co-founder of six biotech companies, as either sole founder or venture capital equity co-founder and manager. Prior to joining Hatch, he was the Founder of Palladio Biosciences, a drug development company developing innovative drugs for the treatment of rare kidney diseases. Serving as Palladio’s first CEO, he raised $20 million in venture capital financing and advanced the company’s lead drug through Phase 2 studies. Prior to Palladio, Lorenzo was a Partner at Care Capital, a leading venture capital and private equity firm investing in private life sciences companies and providing project-based financing for late stage drug development programs. During his 12-year tenure at Care, Lorenzo led the firm’s investments in Elevation Pharmaceuticals (acquired by Sunovion), Anacor Pharmaceuticals (acquired by Pfizer), Minerva Neurosciences (Nasdaq: NERV) and Agile Therapeutics (NASDAQ: AGRX), among others.

Lorenzo received a Laurea in Chemistry, summa cum laude, from the University of Padova, Italy; a Ph.D. in Biochemistry from the Max-Planck-Institute for Brain Research / University of Frankfurt am Main, Germany; and an M.B.A. with Honors from The Wharton School of the University of Pennsylvania. His original research work was published in leading peer-reviewed scientific journals such as Nature, Cell and Neuron, and he is an inventor of two patent families.

Back to Our Team